Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-8443Fax+1 608-262-7174
Education & Training
University of Utah HealthFellowship, Hematopathology, 2005 - 2006- University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2005
Medical University of South CarolinaResidency, Internal Medicine, 1994 - 1997
Loma Linda University School of MedicineClass of 1994
Certifications & Licensure
WI State Medical License 1997 - 2025- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 150 citationsChronic myeloid leukemia, version 2.2021Michael W. Deininger, Neil P. Shah, Jessica K. Altman, Ellin Berman, Ravi Bhatia
Journal of the National Comprehensive Cancer Network. 2020-10-01 - 38 citationsLaboratory testing for cobalamin deficiency in megaloblastic anemia.Matthew J. Oberley, David T. Yang
American Journal of Hematology. 2013-06-01 - 45 citationsSpurious Elevations of Vitamin B12 with Pernicious AnemiaDavid T. Yang, Rachel J Cook
The New England Journal of Medicine. 2012-05-02
Journal Articles
- Unique Dependence on Sos1 in KrasG12D-Induced LeukemogenesisDavid Yang, Erik A Ranheim, Blood
- Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative NeoplasmErik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature
Press Mentions
Banking on Patient Samples to Advance COVID-19 ResearchNovember 20th, 2020
Researchers Identify Mechanism Controlling Red Blood Cell DevelopmentOctober 7th, 2016
Society of Hematopathology Quarterly Case Winter 2016: Primary Myelofibrosis with an Unusual MPL Mutation: Integrating Molecular Testing into the Diagnosis and Prognosis of BCR-ABL1 Negative Myeloproliferative Neoplasms. WMSH1601March 3rd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
